Doddipatala Rao, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 442 W High St, Bryan, OH 43506 Phone: 419-636-4517 Fax: 419-636-6438 |
W Dow Harvey, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 442 W High St, Bryan, OH 43506 Phone: 419-636-4517 Fax: 419-636-6438 |
Anthony Donald Kaminsky, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 433 W High St, Bryan, OH 43506 Phone: 419-636-1131 Fax: 419-636-3100 |
Dr. Ransford Commey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 442 W High St Ste 3, Bryan, OH 43506 Phone: 496-636-4517 Fax: 419-636-6438 |
Dr. Monzur Haque, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 433 W High St, Bryan, OH 43506 Phone: 419-636-1131 Fax: 419-636-3100 |
Dr. Joseph E Centa, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 442 W High St Ste 3, Bryan, OH 43506 Phone: 419-636-4517 |
Jose Parodi, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 433 W High St, Bryan, OH 43506 Phone: 419-636-1131 Fax: 419-636-3100 |
Stenneth G Adams, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 442 W High St Ste 3, Bryan, OH 43506 Phone: 419-636-4517 Fax: 419-636-6438 |
News Archive
International clinical guidelines on the matter are hazy, with different practices followed in different countries. For a serious condition like osteoporosis, affecting millions, it is important to establish clear protocols.
Too much antibiotic can decimate the normal intestinal microbiota, which may never recover its former diversity. That, in turn, renders the GI tract vulnerable to being colonized by pathogens. Now researchers from Memorial Sloan-Kettering Cancer Center, New York, NY, and Centro Superior de Investigaci-n en Salud P-blica, Valencia, Spain, show that reintroducing normal microbial diversity largely eliminated vancomycin-resistant enterococci (VRE) from the intestinal tracts of mice..
Agilent's major new lab informatics suite, the OpenLAB portfolio, is designed to enable customers to easily capture, analyze and share scientific data throughout the lab and across the enterprise. OpenLAB is scalable, open architecture based on industry open standards.
Mylan Inc. today announced that its subsidiary Mylan Technologies Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clonidine Transdermal System USP, 0.1 mg/day, 0.2 mg/day and 0.3 mg/day, the generic version of Boehringer Ingelheim's Catapres-TTSĀ®, a treatment for hypertension.
› Verified 7 days ago